PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed May 15, 2024 · 10-Q · 45 days after period end · 0001140361-24-026295
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$10.60M | -$9.66M | -$8.47M | -$3.05M |
| EPS Diluted | -$0.30 | -$0.32 | -$0.32 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end
